![Philippe Mendels-Flandre](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philippe Mendels-Flandre
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Philippe Mendels-Flandre
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
7
| Public Company | Miscellaneous Commercial Services | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Philippe Mendels-Flandre via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SANOFI | Pharmaceuticals: Major | Investor Relations Contact | |
Medtronic CoreValve LLC
![]() Medtronic CoreValve LLC Medical SpecialtiesHealth Technology Medtronic CoreValve LLC develops transcatheter technologies for failing aortic heart valves. Its proprietary ReValving System allows both percutaneous (PAVR) and transapical aortic valve replacement (TAVR) and is intended to provide an alternative to open-heart surgery. The company was founded by Jacques Seguin in 2001 and is located in Irvine, CA. | Medical Specialties | Director/Board Member | |
FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
REGENXBIO INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Sofinnova Partners SAS
![]() Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Investment Committee Member | |
Florida State University | College/University | Doctorate Degree | |
The Hebrew University of Jerusalem | College/University | Doctorate Degree | |
DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member | |
University College London | College/University | Corporate Officer/Principal | |
Institut National de la Santé & de la Recherche Médicale
![]() Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Orsay | College/University | Graduate Degree | |
ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Chairman | |
Ischemix, Inc.
![]() Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Centre National de la Recherche Scientifique
![]() Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | General Government | Chief Tech/Sci/R&D Officer | |
European Society of Gene & Cell Therapy | President | ||
Université d'Aix-Marseille | College/University | Doctorate Degree | |
Kadmon Pharmaceuticals LLC
![]() Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kadmon Pharmaceuticals LLC manufactures and distributes pharmaceutical products. The company is headquartered in Warrendale, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hotel Bookings International Ltd. | Director/Board Member | ||
Genethon
![]() Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Biotechnology | Chief Tech/Sci/R&D Officer | |
IRBM SpA
![]() IRBM SpA BiotechnologyHealth Technology IRBM SpA is a research organization that specializes in drug discovery and development. IRBM is based in Pomezia, IT, and has subsidiaries in Italy. The Italian company produces recombinant proteins in a homogeneous state and use cyclization to pre-organize compounds for target binding. The private company uses nuclear magnetic resonance (NMR) spectroscopy to study structural biology, clinical research solutions, functional genomics, structure/activity relationships, drug discovery, macromolecule, and small-molecule analysis. The company has a screening library of over 320,000 compounds and use virtual screening and NMR to drive innovation. The company was founded in 2010 by Piero di Lorenzo, who has been the CEO since then. | Biotechnology | Corporate Officer/Principal | |
NUCANA PLC | Biotechnology | Director/Board Member | |
MedDay Pharmaceuticals SAS
![]() MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member | |
Eolas Biosciences Co., Ltd. | Corporate Officer/Principal | ||
IRBM Science Park SpA
![]() IRBM Science Park SpA Miscellaneous Commercial ServicesCommercial Services IRBM Science Park SpA engages in researching and developing biomedical products. The company is headquartered in Pomezia, Italy. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
OBSEVA SA | Pharmaceuticals: Major | Director/Board Member | |
IMMUNEERING CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Centre Hospitalier de Lannemezan
![]() Centre Hospitalier de Lannemezan Hospital/Nursing ManagementHealth Services Centre Hospitalier de Lannemezan is a healthcare company located in Lannemezan Cedex, France. The French company's description mentions a call for applications for a night shift nurse position at the A1 Pole of the Cmp C Claudel. | Hospital/Nursing Management | Corporate Officer/Principal | |
ENYO Pharma SA
![]() ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member | |
INVENTIVA | Biotechnology | Director/Board Member | |
Horama SA
![]() Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Profilomic SA
![]() Profilomic SA Medical/Nursing ServicesHealth Services Profilomic SA develops software solutions. It provides services in chemical, lipidomic and metabolomic analyses using liquid chromatography coupled to high resolution mass spectrometry. The company is headquartered in Boulogne-Billancourt, France. | Medical/Nursing Services | Director/Board Member | |
Women Innovating Together In Healthcare
![]() Women Innovating Together In Healthcare Miscellaneous Commercial ServicesCommercial Services Women Innovating Together In Healthcare operates as an organization of accomplished women. The private company is based in Paris, France. The French company was founded by Rafaèle Elisabeth Tordjman. | Miscellaneous Commercial Services | Founder | |
Wyeth Pharmaceuticals, Inc.
![]() Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Jeito Capital | Chief Executive Officer | ||
Corlieve Therapeutics SAS
![]() Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Corlieve Therapeutics SAS provides neurology services. The company was founded by Richard Porter, Valerie Crepel and Christophe Mulle in November 2019 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
Tollys
![]() Tollys Hospital/Nursing ManagementHealth Services Tollys is a French company that specializes in developing clinical-grade TLR3 ligands for cancer immunotherapy. The company is based in Lyon, France and was founded by Dominique Rigal. The company's co-founders discovered that TLR3 agonists have the potential to induce direct and immunogenic tumor cell death while sparing normal cells. Tollys has filled a patent for a new family of TLR3 ligands and confirmed freedom to operate. The CEO is Vincent Charlon. | Hospital/Nursing Management | Chairman | |
Firalis SA
![]() Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | Biotechnology | Corporate Officer/Principal |
Statistieken
Internationaal
Frankrijk | 25 |
Verenigde Staten | 13 |
Verenigd Koninkrijk | 6 |
Israël | 3 |
Zwitserland | 3 |
Sectoraal
Health Technology | 31 |
Consumer Services | 9 |
Commercial Services | 4 |
Health Services | 4 |
Finance | 2 |
Operationeel
Director/Board Member | 32 |
Corporate Officer/Principal | 19 |
Chief Tech/Sci/R&D Officer | 11 |
Independent Dir/Board Member | 10 |
Chairman | 6 |
Sterkste connecties
- Beurs
- Insiders
- Philippe Mendels-Flandre
- Bedrijfsconnecties